The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Cunningham Everett since 2016.
This trader's CIK number is 1564777.
At the time of last reporting, Cunningham Everett was the Chief Commercial Officer of Exact Sciences Corp. (stock ticker symbol EXAS).
Also see all insider trading activities at Exact Sciences Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | EXAS | 0 | $0 | 7,546 | $439,496 | 12,969 | $0 |
| 2023 | EXAS | 0 | $0 | 16,635 | $1,089,807 | 35,181 | $0 |
| 2022 | EXAS | 0 | $0 | 16,872 | $529,274 | 35,006 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | DGX | 0 | $0 | 5,714 | $496,238 | 0 | $0 |
| 2018 | DGX | 0 | $0 | 108,397 | $11,995,000 | 100,550 | $6,443,596 |
| 2016 | DGX | 0 | $0 | 106,759 | $8,127,367 | 106,759 | $6,601,615 |
2. Quest Diagnostics Inc (DGX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-01 | EXAS | Sale | 136 | 60.15 | 8,180 |
| 2024-02-29 | EXAS | Option Ex | 5,291 | .00 | 0 |
| 2024-03-01 | EXAS | Sale | 2,412 | 59.32 | 143,079 |
| 2024-02-26 | EXAS | Option Ex | 7,678 | .00 | 0 |
| 2024-02-27 | EXAS | Sale | 3,648 | 56.89 | 207,534 |
| 2024-02-22 | EXAS | Sale | 1,350 | 59.78 | 80,703 |
| 2023-10-12 | EXAS | Sale | 13,007 | 66.49 | 864,835 |
| 2023-10-11 | EXAS | Option Ex | 27,504 | .00 | 0 |
| 2023-03-01 | EXAS | Sale | 3,628 | 62.01 | 224,972 |
| 2023-02-27 | EXAS | Option Ex | 7,677 | .00 | 0 |
| 2022-10-11 | EXAS | Option Ex | 35,006 | .00 | 0 |
| 2022-10-12 | EXAS | Sale | 16,872 | 31.37 | 529,274 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-04 | DGX | Sale | 3,892 | 86.81 | 337,864 |
| 2019-02-27 | DGX | Sale | 1,144 | 86.51 | 98,967 |
| 2019-02-26 | DGX | Sale | 352 | 87.06 | 30,645 |
| 2019-02-25 | DGX | Sale | 326 | 88.23 | 28,762 |
| 2018-07-10 | DGX | Sale | 40,328 | 112.00 | 4,516,736 |
| 2018-07-10 | DGX | Option Ex | 40,328 | 71.17 | 2,870,143 |
| 2018-07-02 | DGX | Sale | 68,069 | 109.86 | 7,478,264 |
| 2018-07-02 | DGX | Option Ex | 60,222 | 59.34 | 3,573,453 |
| 2016-05-09 | DGX | Sale | 56,312 | 76.24 | 4,293,395 |
| 2016-05-09 | DGX | Option Ex | 56,312 | 63.65 | 3,583,977 |
| 2016-05-06 | DGX | Option Ex | 50,447 | 59.82 | 3,017,638 |
| 2016-05-06 | DGX | Sale | 50,447 | 76.00 | 3,833,972 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cunningham Everett (Chief Commercial Officer of Exact Sciences Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.